Treatment for Hyperhidrosis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
PRIMARY HYPERHIDROSIS Prevalence and Impacts for the Individual
PRIMARY HYPERHIDROSIS Prevalence and impacts for the individual Alexander Shayesteh Afshar Department of Public Health and Clinical Medicine Dermatology and Venereology Umeå 2018 Copyright © Alexander Shayesteh Afshar 2018 This work is protected by the Swedish Copyright Legislation (Act 1960:729) Dissertation for PhD ISBN: 978-91-7601-822-4 ISSN: 0346-6612 New Series No 1940 Cover art: “Drop Beads” by Grant Ware and Alexander Shayesteh Afshar Electronic version available at: http://umu.diva-portal.org/ Printed by: Umu Print Service Umeå, Sweden 2018 To Ladan, Gabriel and Isabell In medicine we ought to know the causes of sickness and health. And because health and sickness and their causes are sometimes manifest, and sometimes hidden and not to be comprehended except by the study of symptoms, we must also study the symptoms of health and disease. Avicenna 973-1037 CE Table of contents Abstract ............................................................................................ iii Abbreviations .................................................................................... v Sammanfattning på svenska ............................................................ vi List of papers .................................................................................. vii Introduction ....................................................................................... 1 Sweat ................................................................................................................................. 1 Sweat glands .................................................................................................................... -
8.01.19 Treatment of Hyperhidrosis
MEDICAL POLICY – 8.01.19 Treatment of Hyperhidrosis BCBSA Ref. Policy: 8.01.19 Effective Date: Sept. 1, 2021 RELATED MEDICAL POLICIES: Last Revised: Aug. 3, 2021 None Replaces: 8.01.519 Select a hyperlink below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE REVIEW | REFERENCES | HISTORY ∞ Clicking this icon returns you to the hyperlinks menu above. Introduction Hyperhidrosis is a medical term that means excessive sweating. There are two types of hyperhidrosis: primary (focal) hyperhidrosis and secondary hyperhidrosis. Primary focal hyperhidrosis is sweating that’s not due to another medical condition or is a side effect of medication. This kind of sweating is its own medical condition, and it takes place on specific parts of the body such as the hands, feet, underarms, or head and neck. These specific areas are known as focal areas. The other type of hyperhidrosis is secondary hyperhidrosis. This is sweating that happens because of another medical reason such as diabetes, menopause, or obesity. This policy describes when and what types of treatments may be medically necessary for primary focal and secondary hyperhidrosis. Note: The Introduction section is for your general knowledge and is not to be taken as policy coverage criteria. The rest of the policy uses specific words and concepts familiar to medical professionals. It is intended for providers. A provider can be a person, such as a doctor, nurse, psychologist, or dentist. A provider also can be a place where medical care is given, like a hospital, clinic, or lab. This policy informs them about when a service may be covered. -
Hyperhidrosis
Rystedt A, Brismar K, Aquilonius SM, Naver H, Swartling C. J Neurol Neuromedicine (2016) 1(4): Neuromedicine 25-33 www.jneurology.com www.jneurology.com Journal of Neurology & Neuromedicine Mini Review Open Access Hyperhidrosis – an unknown widespread “silent” disorder Alma Rystedt1, Kerstin Brismar2, Sten-Magnus Aquilonius3, Hans Naver4, Carl Swartling1,5 1Hidrosis Clinic, Stockholm, Sweden 2Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden 3Department of Neuroscience, Neurology, Uppsala University, Uppsala University Hospital, Uppsala, Sweden 4Department of Internal Medicine, Neurology, Nyköping Hospital, Nyköping, Sweden 5Department of Medical Sciences, Dermatology and Venereology, Uppsala University, Uppsala, Sweden Article Info ABSTRACT Article Notes Hyperhidrosis is a social, emotional and occupational disability which Received: July 07, 2016 affects close to 3 % of the population. Patients with hyperhidrosis suffer an Accepted: July 21, 2016 extremely negative impact on their quality of life on a par with being severely *Correspondence: affected by psoriasis. Most of the sufferers have the primary genetic form Dr. Carl Swartling of hyperhidrosis. Secondary hyperhidrosis can often be omitted based on Hidrosis Clinic, Warfvinges väg 35 112 51 Stockholm, Sweden anamnestic data, but sometimes further examinations must be performed. E-mail: [email protected] Topical treatment (e.g. aluminium chloride) is the first choice for localised © 2016 Swartling C. This article is distributed under the terms of hyperhidrosis. Botulinum toxin, iontophoresis, microwave thermolysis the Creative Commons Attribution 4.0 International License (miraDry®), and/or systemic medications are indicated if topical treatment is insufficient or not applicable. Endoscopic Thoracic Sympathectomy (ETS) is no longer performed in Sweden due to the serious side effects profile. -
Primary Focal Hyperhidrosis
Primary focal hyperhidrosis Primary focal hyperhidrosis Authors C Christopher Smith, MD David Pariser, MD Section Editors Robert P Dellavalle, MD, PhD, MSPH Mark V Dahl, MD Deputy Editor Abena O Ofori, MD Disclosures All topics are updated as new evidence becomes available and our peer review process is complete. Literature review current through: Oct 2013. | This topic last updated: Aug 14, 2012. INTRODUCTION — Hyperhidrosis (excessive sweating) is a common condition rarely due to significant underlying pathology that may have serious social, emotional, and professional consequences. The diagnosis and treatment of primary focal hyperhidrosis is reviewed here. Night sweats and menopausal hot flashes are discussed separately. (See "Approach to the patient with night sweats" and "Menopausal hot flashes" .) DEFINITION — Hyperhidrosis is the secretion of sweat in amounts greater than physiologically needed for thermoregulation. It is most commonly a chronic idiopathic (primary) condition; however, secondary medical conditions or medications should be excluded. Idiopathic hyperhidrosis localized to certain areas of the body is called primary focal hyperhidrosis. Primary focal hyperhidrosis usually affects the axillae, palms, and soles. A consensus panel suggested the following diagnostic criteria for primary focal hyperhidrosis [ 1 ]: • Focal, visible, excessive sweating of at least six months duration without apparent cause plus at least two of the following characteristics: • Bilateral and relatively symmetric • Impairs daily activities • At least one episode per week • Onset before age 25 • Family history of idiopathic hyperhidrosis • Focal sweating stops during sleep SYMPTOMS — Patients with primary focal hyperhidrosis generally develop symptoms in childhood or adolescence that persist throughout life. Patients have focal symptoms most often localized to the palms, soles, and axillae [ 2-4 ].